Medtronic Reports AMA Category I CPT Code Approvals

Medtronic announced that the American Medical Association approved new Category I CPT codes for its Altaviva and Symplicity Spyral systems, according to Investing News Network.

Investing News Network reported that Medtronic characterized the coding approvals as reflecting growing clinical evidence and physician adoption of solutions addressing urge urinary incontinence and hypertension. The reported action concerns the Altaviva and Symplicity Spyral systems identified by Medtronic.

AMA coding action reported

According to Investing News Network, Medtronic said the American Medical Association approved the new Category I CPT codes. The company named Altaviva and Symplicity Spyral in its announcement.

The report presents the development as a coding approval rather than a general announcement about Medtronic’s broader healthcare technology portfolio. For professionals following reimbursement-related developments, the named systems and Category I CPT designation are the central elements of the update.

Clinical areas named in the announcement

Medtronic linked the coding approvals to solutions addressing urge urinary incontinence and hypertension, Investing News Network reported. The company also said the approvals reflect growing clinical evidence and physician adoption.

The announcement places the update across two clinical areas identified by Medtronic: urge urinary incontinence and hypertension. Investing News Network’s report does not provide further detail on the individual code descriptions, implementation, coverage decisions, or payment levels.

Commercial relevance

Medical-device sales professionals supporting accounts in the clinical areas named by Medtronic can note the company’s reported Category I CPT code approvals when tracking coding-related milestones for Altaviva and Symplicity Spyral.

Investing News Network attributed the announcement to Medtronic, which described the approvals in connection with clinical evidence and physician adoption. The report identifies the AMA as the organization approving the new Category I CPT codes.

As with other reimbursement-related news, the announcement distinguishes the reported coding action from details that were not included in the supplied report. The available evidence names the systems, the clinical areas, the AMA action, and Medtronic’s stated rationale for the approvals.

Source

Investing News Network reported Medtronic’s announcement regarding new American Medical Association Category I CPT code approvals for the Altaviva and Symplicity Spyral systems.